Interface Systems Forecasts 2026 Security Trends

St. Louis, MO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Interface Systems, a leading managed service provider delivering remote video monitoring, commercial security systems, business intelligence, and network to multi-location enterprises, today outlined the security and technology trends expected to define retail, restaurant, and commercial business safety in 2026. The company anticipates an increased shift toward […]

NowVertical Group to Participate in Bristol Capital Hosted Webinar on 10th December 2025

(TSX-V:NOW),(Pinksheets:NOWVF),(PinkSheets:NOWVF), TORONTO, Dec. 03, 2025 (GLOBE NEWSWIRE) — NowVertical Group Inc. (TSXV: NOW) (“NOW” or the “Company”), a leading data and AI solutions provider, is pleased to announce its participation in an upcoming investor webinar hosted by Bristol Capital Ltd. Webinar: Overview of NowVertical's Business Date: December 10, 2025Time: 2pm ESTOverview: The webinar will cover

Ole Smoky® Distillery Announces Launch of New Tennessee Straight Bourbon Whiskey

Premium, four-year barrel-aged bourbon expands the brand's award-winning whiskey line nationwide Ole Smoky Distillery, the most awarded moonshine and flavored whiskey brand in the U.S. and America's most visited distillery, today announced the nationwide release of its newest whiskey: Ole Smoky Tennessee Straight Bourbon Whiskey. Crafted to showcase Ole Smoky's deep Tennessee distilling roots, the

BioCardia Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno

(NASDAQ:BCDA), SUNNYVALE, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) — BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the election of Mr. Marvin Slosman to its Board of Directors, effective December 2, 2025. Dr. Richard Krasno, who has served on the Board

SAGA Metals Completes Phase 1 & Commences Phase 2 of Drilling at Radar Project in Labrador–Confirms Extensive Oxide Mineralization Over 1.5 Km & Provides Corporate Update

(TSX-V:SAGA),(Boerse Frankfurt – Freiverkehr:20H),(OTC US:SAGMF),(Other OTC:SAGMF), VANCOUVER, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“SAGA” or the “Company”) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company advancing critical mineral discoveries, is pleased to announce the successful completion of the first phase of drilling in the Trapper Zone's northern

Aduro Clean Technologies Collaborates with ECOCE to Advance Recycling of Flexible Plastic Packaging in Mexico

(CNSX:ACT.CN),(OTC US:ACTHF),(Other OTC:ACTHF),(Boerse Frankfurt – Freiverkehr:9D5),(NASDAQ:ADUR), LONDON, Ontario, Dec. 03, 2025 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies

(NASDAQ:BNGO), SAN DIEGO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) offering CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), announced today that the clinical lab fee schedule (CLFS) for 2026 posted by Centers for Medicare & Medicaid Services (CMS) indicates an increase

Protara Therapeutics Announces Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naive NMIBC Patients

(NasdaqGM:TARA), TARA-002 demonstrates 72% complete response rate at any time in BCG-Naive patients TARA-002 demonstrates a 69% complete response rate at the 6-month landmark and a 50% complete response rate at the 12-month landmark in BCG-Naive patients Favorable safety and tolerability profile observed with no Grade 3 or greater treatment-related adverse events reported Company obtained

Catheter Precision Secures Tender From Leading Hospital in Hungary

(NYSE MKT: VTAK), FORT MILL, S.C., Dec. 03, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (NYSE American: VTAK), a leading U.S.-based medical device company focusing on advanced solutions in the cardiac electrophysiology market, is proud to announce that its VIVO(TM) system has successfully secured a significant tender at Albert Szent-Gyorgyi Health Centre (Szeged University Hospital)

Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8(R)

(NASDAQ:CLNN), FDA recommended biomarker analyses show statistically significant reductions in NfL and GFAP in participants treated with CNM-Au8 Biomarker improvements are strongly associated with longer survival, reinforcing CNM-Au8's potential disease modifying activity Company has requested a Type C meeting in the first quarter of 2026 to present the newly completed analyses supporting a planned NDA

Scroll to Top